Abstract
Programmed ribosomal frameshifting is a key event during translation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA genome that allows synthesis of the viral RNA-dependent RNA polymerase and downstream proteins. Here, we present the cryo-electron microscopy structure of a translating mammalian ribosome primed for frameshifting on the viral RNA. The viral RNA adopts a pseudoknot structure that lodges at the entry to the ribosomal messenger RNA (mRNA) channel to generate tension in the mRNA and promote frameshifting, whereas the nascent viral polyprotein forms distinct interactions with the ribosomal tunnel. Biochemical experiments validate the structural observations and reveal mechanistic and regulatory features that influence frameshifting efficiency. Finally, we compare compounds previously shown to reduce frameshifting with respect to their ability to inhibit SARS-CoV-2 replication, establishing coronavirus frameshifting as a target for antiviral intervention.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antiviral Agents / pharmacology
-
Codon, Terminator
-
Coronavirus RNA-Dependent RNA Polymerase / biosynthesis
-
Coronavirus RNA-Dependent RNA Polymerase / chemistry
-
Coronavirus RNA-Dependent RNA Polymerase / genetics
-
Cryoelectron Microscopy
-
Fluoroquinolones / pharmacology
-
Frameshifting, Ribosomal* / drug effects
-
Genome, Viral
-
Humans
-
Image Processing, Computer-Assisted
-
Models, Molecular
-
Nucleic Acid Conformation
-
Open Reading Frames
-
Protein Folding
-
RNA, Messenger / chemistry
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
RNA, Ribosomal, 18S / chemistry
-
RNA, Ribosomal, 18S / genetics
-
RNA, Ribosomal, 18S / metabolism
-
RNA, Viral / chemistry
-
RNA, Viral / genetics*
-
RNA, Viral / metabolism
-
Ribosomal Proteins / metabolism
-
Ribosomes / metabolism
-
Ribosomes / ultrastructure*
-
SARS-CoV-2 / drug effects
-
SARS-CoV-2 / genetics*
-
SARS-CoV-2 / physiology
-
Viral Proteins / biosynthesis*
-
Viral Proteins / chemistry
-
Viral Proteins / genetics
-
Virus Replication / drug effects
Substances
-
Antiviral Agents
-
Codon, Terminator
-
Fluoroquinolones
-
RNA, Messenger
-
RNA, Ribosomal, 18S
-
RNA, Viral
-
Ribosomal Proteins
-
Viral Proteins
-
CI 934
-
Coronavirus RNA-Dependent RNA Polymerase
-
NSP12 protein, SARS-CoV-2